DRUGBright Minds Biosciences Inc. Common Stock

77.42USDMkt Cap: 759.65M $P/E:

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which ar…

Key Statistics

Company
Market Cap759.65M $
Enterprise Value455.91M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-12.23M $
Revenue/Share
Last Price77.42 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-13.06
PEG
EV/EBITDA
EV/Revenue
P/S
P/B3.44
EPS (TTM)-2.06
EPS (Forward)-5.93
52W Range
77.248% of range79.56
52W High79.56 USD
52W Low77.24 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-14.91%
ROA-14.49%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-8.69M $
CapEx (TTM)
FCF Margin
FCF Yield-2.47%
Net Debt-307.76M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.00
Current Ratio121.97
Quick Ratio121.44
Book Value/Sh22.54 USD
Cash/Share31.21 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:5
Split DateJul 14, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)170.88 USD
Upside (mean)+120.7%
Target Range145.34 USD221.43 USD
$145.34+120.7% to mean$221.43
# Analysts3
Ownership
Shares Out.9.81M
Float6.21M
Insiders11.94%
Institutions94.85%
Short Interest
Short Ratio3.4d
Short % Float11.78%
Short % Out.9.08%
Shares Short890.85K
Short (prev mo.)952.51K
Technical
SMA 5072.32 (+7.0%)
SMA 20077.08 (+0.4%)
Beta0.09
S&P 52W Chg19.18%
Avg Vol (30d)165.85K
Avg Vol (10d)165.26K
Technical Indicators
RSI (14)50.3
MACD1.8698
MACD Signal1.9850
MACD Hist.-0.1152
BB Upper85.43 USD
BB Middle77.66 USD
BB Lower69.89 USD
BB Width20.02%
ATR (14)4.133 USD
Vol Ratio (20d)0.89x